VOYA Investment Management
RLMD icon

VOYA Investment Management’s Relmada Therapeutics RLMD Stock Holding History

VOYA Investment Management’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,752
Closed -$24.3K – 2984
2023
Q1 		$24.3K Hold
10,752
– – ﹤0.01% 2863
2022
Q4 		$37.5K Sell
10,752
-9,585
-47% -$84.2K ﹤0.01% 2880
2022
Q3 		$753K Buy
20,337
+10,045
+98% +$278K ﹤0.01% 1785
2022
Q2 		$195K Buy
+10,292
New +$224K ﹤0.01% 2407
2021
Q2 		– Sell
-7,064
Closed -$249K – 2883
2021
Q1 		$249K Buy
+7,064
New +$247K ﹤0.01% 2415
2020
Q3 		– Sell
-4,885
Closed -$219K – 2520
2020
Q2 		$219K Buy
+4,885
New +$207K ﹤0.01% 2109

Other funds holding RLMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

VOYA Investment Management's RLMD Position: Q2 2023 in Review

VOYA Investment Management sold out of Relmada Therapeutics (RLMD) in Q2 2023, closing a stake of 10,752 shares — an estimated $24.3K sold.

VOYA Investment Management first reported a position in RLMD in Q2 2020 and held it in 6 quarters. The position peaked at $753K in Q3 2022. 95 funds tracked by Wall St. Rank hold RLMD as of Q2 2023.

  • VOYA Investment Management reported no remaining Relmada Therapeutics position as of Q2 2023 after selling out during the quarter.
  • VOYA Investment Management sold 10,752 Relmada Therapeutics shares in Q2 2023, an estimated $24.3K.
  • VOYA Investment Management first reported a position in Relmada Therapeutics in Q2 2020 and held it in 6 quarters.
  • VOYA Investment Management's Relmada Therapeutics position peaked at $753K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2023.

Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.